Global Kinetics

Global Kinetics is dedicated to improving the lives of patients with Parkinson's disease and other movement disorders through advanced medical technology. Global Kinetics aims to revolutionize the treatment of Parkinson's disease by enabling informed treatment decisions through continuous and objective measurement of key motor symptoms in patients' daily environments.The primary product of Global Kinetics is Parkinson's KinetiGraph® (known as PKG® or Personal KinetiGraph® in the United States), which was developed by neurologists at the world-renowned Florey Institute of Neuroscience and Mental Health in Melbourne, Australia. The PKG® can precisely monitor, quantify, and report on movement patterns associated with neurological conditions, including bradykinesia, dyskinesia, tremor, and rest states.